Treatment Options for Bile Duct Cancer (Cholangiocarcinoma)
Cholangiocarcinoma (CCA), also known as bile duct cancer, is a rare type of cancer that develops in the small tubes called bile ducts. The objective of treatment for cholangiocarcinoma can vary depending on the stage and individual patient. Here are some key points about the objectives of CCA treatment:
- Curative Treatment: Surgery is currently the only possible curative treatment for CCA by removing tumor completely.
- Slowing Down Disease Progression: Treatments aim to shrink the tumor, control its growth, and prevent it from spreading further.
- Prevent Recurrence: Adjuvant therapy refers to additional treatments given after surgery to reduce the risk of cancer recurrence.
An individualized treatment plan incorporates each person's specific characteristics and needs. This approach takes into account factors such as tumor stage, genetic mutations, and overall health status to tailor treatment plans that can optimize outcomes.
Potential treatment options for cholangiocarcinoma, starting with the usual recommended initial treatment, include:
- Surgical Resection: Surgical resection is the primary treatment option for localized forms of cholangiocarcinoma. It involves removing the tumor through surgery. This treatment has the potential to be curative and is considered the central cornerstone of cholangiocarcinoma treatment.
- Adjuvant Systemic Treatment: Adjuvant systemic treatment is recommended after surgical resection or in the palliative setting. It involves using medications such as chemotherapy to target any remaining cancer cells and prevent the recurrence or spread of the disease. The specific medications used will depend on individual factors and should be discussed with a specialized treatment center.
- Targeted Therapies: Increasing knowledge of unique characteristics of cancer cells allows for investigation of targeted therapies as (neo-)adjuvant treatment. Targeted therapies are medications that specifically target certain genetic mutations or proteins involved in cholangiocarcinoma growth. These therapies aim to inhibit the growth of cancer cells and may have a more precise impact on the tumor.
- Locoregional Therapies: When surgery is not possible, locoregional therapies can be considered. These therapies target the treatment to a small region and have the potential to slow tumor progression, decrease tumor size, increase overall survival, and in some cases, allow for cure. Examples of locoregional therapies include:
- High-dose brachytherapy: This treatment is a type of internal radiation therapy. A radioactive source, such as a capsule or wire that emits radiation, is placed inside the tumor.
- Transarterial chemoembolization (TACE): This treatment blocks the blood flow into a tumor and administering high doses of chemotherapy into the tumor.
The specific treatments recommended will depend on factors such as the stage of cholangiocarcinoma, the location of the tumor, and other individual patient characteristics.